UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 9 Issue 10
October-2022
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2210186


Registration ID:
500490

Page Number

b609-b619

Share This Article


Jetir RMS

Title

RECENT ADVANCEMENT IN NASAL DRUG DELIVERY SYSTEM: A CURRENT REVIEW

Abstract

Intranasal medicine delivery – which has been rehearsed for thousands of times, has been given a new parcel of life. It's a useful delivery system for medicines that are active in low boluses and show no minimum oral bioavailability similar as proteins and peptides. Nasal delivery is the logical choice for topical treatment of original conditions in the nose and paranasal sinuses similar as antipathetic and non-allergic rhinitis and sinusitis. The nose is also considered an seductive route for needle-free vaccination and for systemic medicine delivery, especially when rapid-fire immersion and effect are asked. In addition, nasal delivery may help address issues related to poor bioavailability, slow immersion, medicine declination, and adverse events in the gastrointestinal tract and avoids the first-pass metabolism in the liver. The convenience of administration and bettered patient compliance are important in the design of nasal medicine delivery system which remains the favored route of medicine delivery in malignancy of colorful disadvantages. Remedy through intranasal administration has been an accepted form of treatment in the Ayurvedic system of Indian Medicine. Nasal route is salutary for the medicines which are unstable on oral administration because they're significantly degraded in GIT or metabolized by first pass effect in liver. Nasal route is indispensable to parenteral remedy and also useful for long term remedy.

Key Words

Parcel,Medicines,Bioavailability,Vaccination,Convenience,Ayurvedic System, First Pass, GIT.

Cite This Article

"RECENT ADVANCEMENT IN NASAL DRUG DELIVERY SYSTEM: A CURRENT REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 10, page no.b609-b619, October-2022, Available :http://www.jetir.org/papers/JETIR2210186.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"RECENT ADVANCEMENT IN NASAL DRUG DELIVERY SYSTEM: A CURRENT REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 10, page no. ppb609-b619, October-2022, Available at : http://www.jetir.org/papers/JETIR2210186.pdf

Publication Details

Published Paper ID: JETIR2210186
Registration ID: 500490
Published In: Volume 9 | Issue 10 | Year October-2022
DOI (Digital Object Identifier):
Page No: b609-b619
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000289

Print This Page

Current Call For Paper

Jetir RMS